August 19, 2021
10 min listen
Save
Top news this week: FDA OKs single-use bronchoscope; CMS nixes 'most-favored nation' model; and more
This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.
Read the full coverage here:
Single-use bronchoscope receives FDA clearance
Moderna COVID-19 vaccine safe, efficacious in adolescents
Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study
FDA allows third dose of COVID-19 vaccine for immunocompromised patients
CMS nixes 'most-favored nation' pricing model for Medicare Part B
References:
Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.
Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.
Sources/Disclosures
Collapse
Disclosures:
Please see each study for relevant financial disclosures.
Read more about
